232 related articles for article (PubMed ID: 33848267)
1. Myeloid cell-derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10.
Maimon A; Levi-Yahid V; Ben-Meir K; Halpern A; Talmi Z; Priya S; Mizraji G; Mistriel-Zerbib S; Berger M; Baniyash M; Loges S; Burstyn-Cohen T
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33848267
[TBL] [Abstract][Full Text] [Related]
2. Tumour-Secreted Protein S (ProS1) Activates a Tyro3-Erk Signalling Axis and Protects Cancer Cells from Apoptosis.
Al Kafri N; Hafizi S
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31766614
[TBL] [Abstract][Full Text] [Related]
3. The Pros1/Tyro3 axis protects against periodontitis by modulating STAT/SOCS signalling.
Jiang L; Chen XQ; Gao MJ; Lee W; Zhou J; Zhao YF; Wang GD
J Cell Mol Med; 2019 Apr; 23(4):2769-2781. PubMed ID: 30729671
[TBL] [Abstract][Full Text] [Related]
4. Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC.
Giroud P; Renaudineau S; Gudefin L; Calcei A; Menguy T; Rozan C; Mizrahi J; Caux C; Duong V; Valladeau-Guilemond J
Front Immunol; 2020; 11():564133. PubMed ID: 33101282
[TBL] [Abstract][Full Text] [Related]
5. Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response.
Ubil E; Caskey L; Holtzhausen A; Hunter D; Story C; Earp HS
J Clin Invest; 2018 Jun; 128(6):2356-2369. PubMed ID: 29708510
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-Derived Protein S Facilitates Apoptotic Polymorphonuclear Cell Clearance by Resolution Phase Macrophages and Supports Their Reprogramming.
Lumbroso D; Soboh S; Maimon A; Schif-Zuck S; Ariel A; Burstyn-Cohen T
Front Immunol; 2018; 9():358. PubMed ID: 29545796
[TBL] [Abstract][Full Text] [Related]
7. The first laminin G-like domain of protein S is essential for binding and activation of Tyro3 receptor and intracellular signalling.
Al Kafri N; Ahnström J; Teraz-Orosz A; Chaput L; Singh N; Villoutreix BO; Hafizi S
Biochem Biophys Rep; 2022 Jul; 30():101263. PubMed ID: 35518197
[TBL] [Abstract][Full Text] [Related]
8. MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis.
Cook RS; Jacobsen KM; Wofford AM; DeRyckere D; Stanford J; Prieto AL; Redente E; Sandahl M; Hunter DM; Strunk KE; Graham DK; Earp HS
J Clin Invest; 2013 Aug; 123(8):3231-42. PubMed ID: 23867499
[TBL] [Abstract][Full Text] [Related]
9. MERTK Acts as a Costimulatory Receptor on Human CD8
Peeters MJW; Dulkeviciute D; Draghi A; Ritter C; Rahbech A; Skadborg SK; Seremet T; Carnaz Simões AM; Martinenaite E; Halldórsdóttir HR; Andersen MH; Olofsson GH; Svane IM; Rasmussen LJ; Met Ö; Becker JC; Donia M; Desler C; Thor Straten P
Cancer Immunol Res; 2019 Sep; 7(9):1472-1484. PubMed ID: 31266785
[TBL] [Abstract][Full Text] [Related]
10. TAM Receptor Inhibition-Implications for Cancer and the Immune System.
Aehnlich P; Powell RM; Peeters MJW; Rahbech A; Thor Straten P
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33801886
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.
Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z
J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors.
Beury DW; Parker KH; Nyandjo M; Sinha P; Carter KA; Ostrand-Rosenberg S
J Leukoc Biol; 2014 Dec; 96(6):1109-18. PubMed ID: 25170116
[TBL] [Abstract][Full Text] [Related]
13. Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6.
Geng K; Kumar S; Kimani SG; Kholodovych V; Kasikara C; Mizuno K; Sandiford O; Rameshwar P; Kotenko SV; Birge RB
Front Immunol; 2017; 8():1521. PubMed ID: 29176978
[TBL] [Abstract][Full Text] [Related]
14. BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal Melanomas.
Kaler CJ; Dollar JJ; Cruz AM; Kuznetsoff JN; Sanchez MI; Decatur CL; Licht JD; Smalley KSM; Correa ZM; Kurtenbach S; Harbour JW
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954340
[TBL] [Abstract][Full Text] [Related]
15. CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells.
Fortunato O; Belisario DC; Compagno M; Giovinazzo F; Bracci C; Pastorino U; Horenstein A; Malavasi F; Ferracini R; Scala S; Sozzi G; Roz L; Roato I; Bertolini G
Front Immunol; 2020; 11():02168. PubMed ID: 33123122
[TBL] [Abstract][Full Text] [Related]
16. Mouse 4T1 Breast Cancer Cell-Derived Exosomes Induce Proinflammatory Cytokine Production in Macrophages via miR-183.
Guo J; Duan Z; Zhang C; Wang W; He H; Liu Y; Wu P; Wang S; Song M; Chen H; Chen C; Si Q; Xiang R; Luo Y
J Immunol; 2020 Nov; 205(10):2916-2925. PubMed ID: 32989094
[TBL] [Abstract][Full Text] [Related]
17. Re-evaluation of IL-10 signaling reveals novel insights on the contribution of the intracellular domain of the IL-10R2 chain.
Wilbers RHP; van Raaij DR; Westerhof LB; Bakker J; Smant G; Schots A
PLoS One; 2017; 12(10):e0186317. PubMed ID: 29016674
[TBL] [Abstract][Full Text] [Related]
18. Mertk: An emerging target in cancer biology and immuno-oncology.
Lahey KC; Gadiyar V; Hill A; Desind S; Wang Z; Davra V; Patel R; Zaman A; Calianese D; Birge RB
Int Rev Cell Mol Biol; 2022; 368():35-59. PubMed ID: 35636929
[TBL] [Abstract][Full Text] [Related]
19. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors.
Ye Z; Shi M; Chan T; Sas S; Xu S; Xiang J
Cancer Gene Ther; 2007 Jul; 14(7):661-75. PubMed ID: 17479109
[TBL] [Abstract][Full Text] [Related]
20. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]